Immunosuppressive Drugs in Kidney Transplantation

By R. Marcén. Drugs, 2009

769 citations recorded by the source corpus.

Subfields: Epidemiology, Oncology, Transplantation

View Paper: https://www.semanticscholar.org/paper/93fd3bac00fe388d4d6ea1fafaac2d94dfc2f7a7

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. Marcello Tonelli
2. M. Costanzo
3. Natasha Wiebe
4. S. Klarenbach
5. A. Dipchand
6. R. Starling
7. Gonzalo Gonzales-Stawinski
8. A. Zuckermann

Citations in the corpus

• Systematic Review: Kidney Transplantation Compared With Dialysis in Clinically Relevant Outcomes (2011, background): “Immunosuppressive medications used in transplant recipients may cause anemia, hypertension, glucose intolerance and dyslipidemia (91).”
• The International Society of Heart and Lung Transplantation Guidelines for the care of heart transplant recipients. (2010, background): “6 After signals 1 and 2 there is activation of a tyrosine kinase ZAP-70 which then triggers 3 pathways leading to upregulation of gene expression in the T-cell: 1) the calcium-calcineurin pathway, 2) the nuclear factor-kappa B pathway, and 3) the mitogenactivated protein kinase pathway.(7) Activatio”